These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24513048)

  • 1. 1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase.
    Keith JM; Hawryluk N; Apodaca RL; Chambers A; Pierce JM; Seierstad M; Palmer JA; Webb M; Karbarz MJ; Scott BP; Wilson SJ; Luo L; Wennerholm ML; Chang L; Rizzolio M; Chaplan SR; Breitenbucher JG
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1280-4. PubMed ID: 24513048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase inhibitors.
    Kono M; Matsumoto T; Imaeda T; Kawamura T; Fujimoto S; Kosugi Y; Odani T; Shimizu Y; Matsui H; Shimojo M; Kori M
    Bioorg Med Chem; 2014 Feb; 22(4):1468-78. PubMed ID: 24440478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure based design of novel irreversible FAAH inhibitors.
    Wang JL; Bowen SJ; Schweitzer BA; Madsen HM; McDonald J; Pelc MJ; Tenbrink RE; Beidler D; Thorarensen A
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5970-4. PubMed ID: 19765986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, SAR study, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase (FAAH) inhibitors.
    Kono M; Matsumoto T; Kawamura T; Nishimura A; Kiyota Y; Oki H; Miyazaki J; Igaki S; Behnke CA; Shimojo M; Kori M
    Bioorg Med Chem; 2013 Jan; 21(1):28-41. PubMed ID: 23218778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain.
    Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Schweitzer BA; Wilcox MV; McDonald J; Smith SE; Foltin S; Rumsey J; Yang YS; Walker MC; Kamtekar S; Beidler D; Thorarensen A
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6545-53. PubMed ID: 21924613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors.
    Gustin DJ; Ma Z; Min X; Li Y; Hedberg C; Guimaraes C; Porter AC; Lindstrom M; Lester-Zeiner D; Xu G; Carlson TJ; Xiao S; Meleza C; Connors R; Wang Z; Kayser F
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2492-6. PubMed ID: 21392988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ω-Imidazolyl- and ω-Tetrazolylalkylcarbamates as Inhibitors of Fatty Acid Amide Hydrolase: Biological Activity and in vitro Metabolic Stability.
    Terwege T; Hanekamp W; Garzinsky D; König S; Koch O; Lehr M
    ChemMedChem; 2016 Feb; 11(4):429-43. PubMed ID: 26732805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASP8477, a fatty acid amide hydrolase inhibitor, exerts analgesic effects in rat models of neuropathic and dysfunctional pain.
    Kiso T; Watabiki T; Sekizawa T
    Eur J Pharmacol; 2020 Aug; 881():173194. PubMed ID: 32445705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-(triazolyl)methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors.
    Colombano G; Albani C; Ottonello G; Ribeiro A; Scarpelli R; Tarozzo G; Daglian J; Jung KM; Piomelli D; Bandiera T
    ChemMedChem; 2015 Feb; 10(2):380-95. PubMed ID: 25338703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors.
    Sunduru N; Svensson M; Cipriano M; Marwaha S; Andersson CD; Svensson R; Fowler CJ; Elofsson M
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):513-521. PubMed ID: 28114819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain.
    Brindisi M; Borrelli G; Brogi S; Grillo A; Maramai S; Paolino M; Benedusi M; Pecorelli A; Valacchi G; Di Cesare Mannelli L; Ghelardini C; Allarà M; Ligresti A; Minetti P; Campiani G; di Marzo V; Butini S; Gemma S
    ChemMedChem; 2018 Oct; 13(19):2090-2103. PubMed ID: 30085402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
    Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH).
    Aghazadeh Tabrizi M; Baraldi PG; Ruggiero E; Saponaro G; Baraldi S; Romagnoli R; Martinelli A; Tuccinardi T
    Eur J Med Chem; 2015 Jun; 97():289-305. PubMed ID: 26002335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding mode of new (thio)hydantoin inhibitors of fatty acid amide hydrolase: comparison with two original compounds, OL-92 and JP104.
    Michaux C; Muccioli GG; Lambert DM; Wouters J
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4772-6. PubMed ID: 16844375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.
    Mor M; Rivara S; Lodola A; Plazzi PV; Tarzia G; Duranti A; Tontini A; Piersanti G; Kathuria S; Piomelli D
    J Med Chem; 2004 Oct; 47(21):4998-5008. PubMed ID: 15456244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH).
    Timmons A; Seierstad M; Apodaca R; Epperson M; Pippel D; Brown S; Chang L; Scott B; Webb M; Chaplan SR; Breitenbucher JG
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2109-13. PubMed ID: 18289847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-Heteroaryl-3-phenoxypropan-2-ones as inhibitors of cytosolic phospholipase A₂α and fatty acid amide hydrolase: Effect of the replacement of the ether oxygen with sulfur and nitrogen moieties on enzyme inhibition and metabolic stability.
    Sundermann T; Fabian J; Hanekamp W; Lehr M
    Bioorg Med Chem; 2015 May; 23(10):2579-92. PubMed ID: 25862211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Heterocycle-phenyl N-alkylcarbamates as FAAH inhibitors: design, synthesis and 3D-QSAR studies.
    Käsnänen H; Myllymäki MJ; Minkkilä A; Kataja AO; Saario SM; Nevalainen T; Koskinen AM; Poso A
    ChemMedChem; 2010 Feb; 5(2):213-31. PubMed ID: 20024981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Holtfrerich A; Hanekamp W; Lehr M
    Eur J Med Chem; 2013 May; 63():64-75. PubMed ID: 23455058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.
    Gattinoni S; Simone CD; Dallavalle S; Fezza F; Nannei R; Battista N; Minetti P; Quattrociocchi G; Caprioli A; Borsini F; Cabri W; Penco S; Merlini L; Maccarrone M
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4406-11. PubMed ID: 20591666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.